The COVID-19 infection: lessons from the Italian experience.


Journal

Journal of public health policy
ISSN: 1745-655X
Titre abrégé: J Public Health Policy
Pays: England
ID NLM: 8006508

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 31 5 2020
medline: 14 8 2020
entrez: 31 5 2020
Statut: ppublish

Résumé

The first case of the new coronavirus, COVID-19, was reported in China on 17 November 2019. By the end of March 2020, the rapid global spread of infection affected over 1 million people. Italy is one of the countries most impacted, with over 100,000 positive cases identified. The first detected cases were reported on 21 February 2020 in two Italian towns: Vo' Euganeo in the Province of Padua, Veneto region, and Codogno, in the Province of Lodi, Lombardy. In the next weeks the epidemic spread quickly across the country but mainly in the north of Italy. The two regions: Veneto and Lombardy, implemented different strategies to control the viral spread. In Veneto, health personnel tested both symptomatic and asymptomatic subjects, while in Lombardy only symptomatic cases were investigated. We analyzed the evolution of the epidemic in these regions and showed that testing both symptomatic and asymptomatic cases is a more effective strategy to mitigate the epidemic impact. We strongly recommend that decision-makers: ensure early isolation of symptomatic patients and rapid identification of their contacts; maximize testing rapidly, especially among people with multiple daily contacts with infected populations, high exposure to the public in essential services; rapidly increase diagnostic capacity by mobilizing trained personnel capable of performing rRT-PCR on respiratory samples; equip the population with protective masks.

Identifiants

pubmed: 32472024
doi: 10.1057/s41271-020-00229-y
pii: 10.1057/s41271-020-00229-y
pmc: PMC7257358
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-244

Références

Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701

Auteurs

Paola Romagnani (P)

Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.

Guido Gnone (G)

Genoa Aquarium Foundation, Genoa, Italy.

Francesco Guzzi (F)

Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.

Simone Negrini (S)

Department of Internal Medicine, University of Genoa and IRCCS IST-Ospedale San Martino, Genoa, Italy.

Andrea Guastalla (A)

Department of Internal Medicine, University of Genoa and IRCCS IST-Ospedale San Martino, Genoa, Italy.

Francesco Annunziato (F)

Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.

Sergio Romagnani (S)

Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy. sergio.romagnani@unifi.it.

Raffaele De Palma (R)

Department of Internal Medicine, University of Genoa and IRCCS IST-Ospedale San Martino, Genoa, Italy. raffaele.depalma@unige.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH